🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hugh D. C. Smyth

ORCID: 0000-0002-6582-5869

Also affiliated with The University of Texas at Austin

MedicinePharmacology, Toxicology and PharmaceuticsAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms”.

Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms

Journal of Nanobiotechnology(2020)10.1186/s12951-020-0588-6

N/A

0DataRank · unranked

171 citations

Stephen J. Wawrzyniec, Michael Kopciuch, Yekaterina I. Brandt, Antonio C. Rivera, Nathan J. Withers +6 more

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments

Pharmaceutics(2020)10.3390/pharmaceutics12111042

N/A

0DataRank · unranked

151 citations

J. Sánchez Leal, Melissa Soto, Hugh D. C. Smyth, Debadyuti Ghosh, Hairui Zhang

Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.03.032

N/A

0DataRank · unranked

59 citations

Xiujuan Peng, Xinquan Liu, Dhivya Arasappan, Dennis Wylie, Sarah H. Schwartz +5 more

Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients

AAPS PharmSciTech(2020)10.1208/s12249-020-01682-4

N/A

0DataRank · unranked

19 citations

Patricia P. Martins, Michael Zamloot, Shawn A. Kucera, Robert O. Williams, Hugh D. C. Smyth +2 more

Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

PLoS ONE(2021)10.1371/journal.pone.0246803

N/A

0DataRank · unranked

65 citations

Hyojong Seo, Zachary N. Warnken, Li Ding, Sang Heui Seo, Hugh D. C. Smyth +1 more

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab305

N/A

0DataRank · unranked

41 citations

James M. Anderson, Annaliesa S. Anderson, David Baker, Jay Bradner, Kyle R. Brimacombe +37 more

Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder

Journal of Pharmaceutical Sciences(2021)10.1016/j.xphs.2021.08.022

N/A

0DataRank · unranked

19 citations

Li Ding, Tian Wu, Michael Schneider, Ryan Khalaf, Hugh D. C. Smyth +1 more

Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics

European Journal of Pharmaceutical Sciences(2023)10.1016/j.ejps.2023.106470

N/A

0DataRank · unranked

10 citations

Andrea N. Trementozzi, Patricia P. Martins, Jagruti Parekh, John J. Koleng, Hugh D. C. Smyth +2 more